Advertisement
YOU ARE HERE: LAT HomeCollectionsCollagen Corp
IN THE NEWS

Collagen Corp

FEATURED ARTICLES
BUSINESS
January 8, 1992 | From Times Staff and Wire Reports
Product Liability Suit Against Collagen Dropped: Palo Alto-based Collagen Corp. announced that Marlene Waller dropped her lawsuit in which she claimed that injectable collagen treatments caused her to develop scleroderma and that a federal court in Texas denied the motion for a new trial of a Houston woman who alleged that collagen injections caused her to develop a rare autoimmune disease. Circuit Court Judge Joseph N. Casciato of Cook County, Ill.
ARTICLES BY DATE
BUSINESS
January 9, 1997 | Times Staff and Wire Reports
Collagen Corp. said it plans to separate its profitable plastic surgery implant business, possibly through a spinoff or initial public offering. The unit makes and sells collagen and other implants used in plastic surgery. Collagen's other business, Collagen Technologies, researches and develops collagen- and polymer-based products. It also develops products for soft-tissue repair, orthopedics, vascular surgery and ophthalmology.
Advertisement
BUSINESS
September 18, 1991 | From Times Staff and Wire Reports
Collagen Corp. to Back Doctors: The Palo Alto company said it will indemnify doctors against lawsuits filed over collagen. It made the announcement four days after federal health officials announced that collagen users have a higher incidence of two connective tissue diseases, though they have not found a link or causal relationship between collagen and the diseases. "We are confident in the safety of our injectable collagen products," said Howard D.
CALIFORNIA | LOCAL
December 12, 1992
No one disputes the need for a strong FDA to protect consumers ("Report Charges FDA Failure on Wrinkle Products," Nov. 23). But it is a shame the House Government Operations Committee, in reviewing the FDA in its recently released Human Resources and Intergovernmental Relations Subcommittee report, can't get the facts straight. It is also a shame that you chose not to research the facts behind the report. The article implies that Collagen Corp. promotes off-label uses of its collagen products and sells products that may be unsafe.
BUSINESS
October 21, 1991 | MARTHA GROVES, TIMES STAFF WRITER
Come Friday, Collagen Corp. will find itself under a microscope in Washington. On that day, the Food and Drug Administration will submit data to a panel of scientific experts who will attempt to evaluate just how safe are Collagen's 10-year-old injectable products for smoothing wrinkles and acne scars. If it sounds as if the cart might have gone before the horse, at least one powerful congressman would agree. Rep. John H.
BUSINESS
January 9, 1997 | Times Staff and Wire Reports
Collagen Corp. said it plans to separate its profitable plastic surgery implant business, possibly through a spinoff or initial public offering. The unit makes and sells collagen and other implants used in plastic surgery. Collagen's other business, Collagen Technologies, researches and develops collagen- and polymer-based products. It also develops products for soft-tissue repair, orthopedics, vascular surgery and ophthalmology.
CALIFORNIA | LOCAL
December 12, 1992
No one disputes the need for a strong FDA to protect consumers ("Report Charges FDA Failure on Wrinkle Products," Nov. 23). But it is a shame the House Government Operations Committee, in reviewing the FDA in its recently released Human Resources and Intergovernmental Relations Subcommittee report, can't get the facts straight. It is also a shame that you chose not to research the facts behind the report. The article implies that Collagen Corp. promotes off-label uses of its collagen products and sells products that may be unsafe.
BUSINESS
September 14, 1991 | From Associated Press
A company that makes injectable collagen Friday rejected a Food and Drug Administration finding that users have a higher rate of two rare diseases. Frank DeLustro, vice president of scientific affairs for Collagen Corp., said the company's natural protein products have proven safe. Collagen has been used to treat allergic reactions for decades, he said. Collagen, a natural bovine protein, is injected under the skin to smooth wrinkles and repair acne and scars.
BUSINESS
November 10, 1985 | KATHLEEN DAY, Times Staff Writer
The essence of Collagen Corp. is flesh and bone. From a sticky glop that is among the most common materials in animal and human tissue, the Palo Alto company has concocted a unique product. It makes a goo of natural proteins called collagens that it extracts from cowhide and modifies for human use. It then sells the stuff to doctors, who inject it under patients' skin to smooth wrinkles and scars or to rebuild tissue during plastic surgery.
BUSINESS
January 8, 1992 | From Times Staff and Wire Reports
Product Liability Suit Against Collagen Dropped: Palo Alto-based Collagen Corp. announced that Marlene Waller dropped her lawsuit in which she claimed that injectable collagen treatments caused her to develop scleroderma and that a federal court in Texas denied the motion for a new trial of a Houston woman who alleged that collagen injections caused her to develop a rare autoimmune disease. Circuit Court Judge Joseph N. Casciato of Cook County, Ill.
BUSINESS
October 21, 1991 | MARTHA GROVES, TIMES STAFF WRITER
Come Friday, Collagen Corp. will find itself under a microscope in Washington. On that day, the Food and Drug Administration will submit data to a panel of scientific experts who will attempt to evaluate just how safe are Collagen's 10-year-old injectable products for smoothing wrinkles and acne scars. If it sounds as if the cart might have gone before the horse, at least one powerful congressman would agree. Rep. John H.
BUSINESS
September 18, 1991 | From Times Staff and Wire Reports
Collagen Corp. to Back Doctors: The Palo Alto company said it will indemnify doctors against lawsuits filed over collagen. It made the announcement four days after federal health officials announced that collagen users have a higher incidence of two connective tissue diseases, though they have not found a link or causal relationship between collagen and the diseases. "We are confident in the safety of our injectable collagen products," said Howard D.
BUSINESS
September 14, 1991 | From Associated Press
A company that makes injectable collagen Friday rejected a Food and Drug Administration finding that users have a higher rate of two rare diseases. Frank DeLustro, vice president of scientific affairs for Collagen Corp., said the company's natural protein products have proven safe. Collagen has been used to treat allergic reactions for decades, he said. Collagen, a natural bovine protein, is injected under the skin to smooth wrinkles and repair acne and scars.
BUSINESS
November 10, 1985 | KATHLEEN DAY, Times Staff Writer
The essence of Collagen Corp. is flesh and bone. From a sticky glop that is among the most common materials in animal and human tissue, the Palo Alto company has concocted a unique product. It makes a goo of natural proteins called collagens that it extracts from cowhide and modifies for human use. It then sells the stuff to doctors, who inject it under patients' skin to smooth wrinkles and scars or to rebuild tissue during plastic surgery.
BUSINESS
January 5, 1989
IDEC Pharmaceuticals Corp. of La Jolla and Mountain View has appointed Clifford Orent as general counsel and vice president for corporate development, effective Feb. 13. Orent, 38, will lead the development of IDEC's business agreements with major corporate partners in the United States and abroad and will manage IDEC's legal affairs and licensing activities. He joins IDEC from Genentech, where he filled a number of management positions after joining the company in 1983.
BUSINESS
April 8, 1985
Gordon J. Louttit has been named a vice president of Whittaker Corp., Los Angeles. James C. Tollefson has joined Golden State Sanwa Bank, Los Angeles, as senior vice president and manager of the commercial banking group. Electronic Space Products International, Westlake Village, named Larraine D. Segil president and chief executive. James S.
Los Angeles Times Articles
|